- Home
- SUPN vs BKU Comparison
SUPN vs BKU Comparison
Compare SUPN & BKU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SUPN | BKU |
|---|---|---|
| Founded | 2005 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 3.4B |
| IPO Year | 2010 | 2010 |
Fundamental Metrics
Financial Performance| Metric | SUPN | BKU |
|---|---|---|
| Price | $44.42 | $47.41 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 12 |
| Target Price | ★ $61.60 | $51.58 |
| AVG Volume (30 Days) | ★ 535.7K | 530.9K |
| Earning Date | 05-05-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 2.87% |
| EPS Growth | N/A | ★ 14.61 |
| EPS | N/A | ★ 0.83 |
| Revenue | ★ $392,755,000.00 | $21,732,000.00 |
| Revenue This Year | $22.70 | $16.26 |
| Revenue Next Year | $19.14 | $4.78 |
| P/E Ratio | ★ N/A | $56.33 |
| Revenue Growth | N/A | ★ 7.45 |
| 52 Week Low | $31.16 | $33.59 |
| 52 Week High | $59.68 | $52.11 |
Technical Indicators
Market Signals| Indicator | SUPN | BKU |
|---|---|---|
| Relative Strength Index (RSI) | 38.79 | 51.31 |
| Support Level | $43.67 | $46.77 |
| Resistance Level | $52.36 | $47.41 |
| Average True Range (ATR) | 1.41 | 1.02 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 41.04 | 42.98 |
Price Performance
Historical ComparisonAbout SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.
About BKU BankUnited Inc.
BankUnited Inc is a bank holding company with one wholly owned subsidiary, BankUnited. The bank provides a full range of banking services through banking centers located throughout Florida, as well as New York City. The company is a commercially focused regional bank focusing on small and middle-market businesses. The company also provides certain commercial lending and deposit products on a national platform. The Bank offers a comprehensive suite of commercial lending and deposit products including commercial lending and deposit products through national platforms and certain consumer deposit products through an online channel.